Daniel A. Weintraub

This study examines the association between microglial reactivity and neuronal α-synucleinopathy in specific hippocampal subfields in Lewy body disease patients.

The paper identifies plasma α-synuclein conformations that distinguish Parkinson's disease from dementia with Lewy bodies and predict cognitive decline in PD.

This paper proposes a 3D CNN for classifying Alzheimer's and Parkinson's disease using T1-weighted MRI, achieving higher ROC-AUC than random forest on multiple datasets.

This paper validates serum neurofilament light chain (NfL) as a biomarker for Parkinson's disease progression, showing increased levels in PD patients compared to healthy controls and a longitudinal increase correlating with clinical severity.

This study identifies two genome-wide significant variants associated with Parkinson's disease progression and replicates known risk variants' effects on motor and cognitive decline.